PNG  IHDRQgAMA a cHRMz&u0`:pQ<bKGDgmIDATxwUﹻ& ^CX(J I@ "% (** BX +*i"]j(IH{~R)[~>h{}gy)I$Ij .I$I$ʊy@}x.: $I$Ii}VZPC)I$IF ^0ʐJ$I$Q^}{"r=OzI$gRZeC.IOvH eKX $IMpxsk.쒷/&r[޳<v| .I~)@$updYRa$I |M.e JaֶpSYR6j>h%IRز if&uJ)M$I vLi=H;7UJ,],X$I1AҒJ$ XY XzI@GNҥRT)E@;]K*Mw;#5_wOn~\ DC&$(A5 RRFkvIR}l!RytRl;~^ǷJj اy뷦BZJr&ӥ8Pjw~vnv X^(I;4R=P[3]J,]ȏ~:3?[ a&e)`e*P[4]T=Cq6R[ ~ޤrXR Հg(t_HZ-Hg M$ãmL5R uk*`%C-E6/%[t X.{8P9Z.vkXŐKjgKZHg(aK9ڦmKjѺm_ \#$5,)-  61eJ,5m| r'= &ڡd%-]J on Xm|{ RҞe $eڧY XYrԮ-a7RK6h>n$5AVڴi*ֆK)mѦtmr1p| q:흺,)Oi*ֺK)ܬ֦K-5r3>0ԔHjJئEZj,%re~/z%jVMڸmrt)3]J,T K֦OvԒgii*bKiNO~%PW0=dii2tJ9Jݕ{7"I P9JKTbu,%r"6RKU}Ij2HKZXJ,妝 XYrP ެ24c%i^IK|.H,%rb:XRl1X4Pe/`x&P8Pj28Mzsx2r\zRPz4J}yP[g=L) .Q[6RjWgp FIH*-`IMRaK9TXcq*I y[jE>cw%gLRԕiFCj-ďa`#e~I j,%r,)?[gp FI˨mnWX#>mʔ XA DZf9,nKҲzIZXJ,L#kiPz4JZF,I,`61%2s $,VOϚ2/UFJfy7K> X+6 STXIeJILzMfKm LRaK9%|4p9LwJI!`NsiazĔ)%- XMq>pk$-$Q2x#N ؎-QR}ᶦHZډ)J,l#i@yn3LN`;nڔ XuX5pF)m|^0(>BHF9(cզEerJI rg7 4I@z0\JIi䵙RR0s;$s6eJ,`n 䂦0a)S)A 1eJ,堌#635RIgpNHuTH_SԕqVe ` &S)>p;S$魁eKIuX`I4춒o}`m$1":PI<[v9^\pTJjriRŭ P{#{R2,`)e-`mgj~1ϣLKam7&U\j/3mJ,`F;M'䱀 .KR#)yhTq;pcK9(q!w?uRR,n.yw*UXj#\]ɱ(qv2=RqfB#iJmmL<]Y͙#$5 uTU7ӦXR+q,`I}qL'`6Kͷ6r,]0S$- [RKR3oiRE|nӦXR.(i:LDLTJjY%o:)6rxzҒqTJjh㞦I.$YR.ʼnGZ\ֿf:%55 I˼!6dKxm4E"mG_ s? .e*?LRfK9%q#uh$)i3ULRfK9yxm܌bj84$i1U^@Wbm4uJ,ҪA>_Ij?1v32[gLRD96oTaR׿N7%L2 NT,`)7&ƝL*꽙yp_$M2#AS,`)7$rkTA29_Iye"|/0t)$n XT2`YJ;6Jx".e<`$) PI$5V4]29SRI>~=@j]lp2`K9Jaai^" Ԋ29ORI%:XV5]JmN9]H;1UC39NI%Xe78t)a;Oi Ҙ>Xt"~G>_mn:%|~ޅ_+]$o)@ǀ{hgN;IK6G&rp)T2i୦KJuv*T=TOSV>(~D>dm,I*Ɛ:R#ۙNI%D>G.n$o;+#RR!.eU˽TRI28t)1LWϚ>IJa3oFbu&:tJ*(F7y0ZR ^p'Ii L24x| XRI%ۄ>S1]Jy[zL$adB7.eh4%%누>WETf+3IR:I3Xה)3אOۦSRO'ٺ)S}"qOr[B7ϙ.edG)^ETR"RtRݜh0}LFVӦDB^k_JDj\=LS(Iv─aTeZ%eUAM-0;~˃@i|l @S4y72>sX-vA}ϛBI!ݎߨWl*)3{'Y|iSlEڻ(5KtSI$Uv02,~ԩ~x;P4ցCrO%tyn425:KMlD ^4JRxSهF_}شJTS6uj+ﷸk$eZO%G*^V2u3EMj3k%)okI]dT)URKDS 7~m@TJR~荪fT"֛L \sM -0T KfJz+nإKr L&j()[E&I ߴ>e FW_kJR|!O:5/2跌3T-'|zX ryp0JS ~^F>-2< `*%ZFP)bSn"L :)+pʷf(pO3TMW$~>@~ū:TAIsV1}S2<%ޟM?@iT ,Eūoz%i~g|`wS(]oȤ8)$ ntu`өe`6yPl IzMI{ʣzʨ )IZ2= ld:5+請M$-ї;U>_gsY$ÁN5WzWfIZ)-yuXIfp~S*IZdt;t>KūKR|$#LcԀ+2\;kJ`]YǔM1B)UbG"IRߊ<xܾӔJ0Z='Y嵤 Leveg)$znV-º^3Ւof#0Tfk^Zs[*I꯳3{)ˬW4Ւ4 OdpbZRS|*I 55#"&-IvT&/윚Ye:i$ 9{LkuRe[I~_\ؠ%>GL$iY8 9ܕ"S`kS.IlC;Ҏ4x&>u_0JLr<J2(^$5L s=MgV ~,Iju> 7r2)^=G$1:3G< `J3~&IR% 6Tx/rIj3O< ʔ&#f_yXJiގNSz; Tx(i8%#4 ~AS+IjerIUrIj362v885+IjAhK__5X%nV%Iͳ-y|7XV2v4fzo_68"S/I-qbf; LkF)KSM$ Ms>K WNV}^`-큧32ŒVؙGdu,^^m%6~Nn&͓3ŒVZMsRpfEW%IwdǀLm[7W&bIRL@Q|)* i ImsIMmKmyV`i$G+R 0tV'!V)֏28vU7͒vHꦼtxꗞT ;S}7Mf+fIRHNZUkUx5SAJㄌ9MqμAIRi|j5)o*^'<$TwI1hEU^c_j?Е$%d`z cyf,XO IJnTgA UXRD }{H}^S,P5V2\Xx`pZ|Yk:$e ~ @nWL.j+ϝYb퇪bZ BVu)u/IJ_ 1[p.p60bC >|X91P:N\!5qUB}5a5ja `ubcVxYt1N0Zzl4]7­gKj]?4ϻ *[bg$)+À*x쳀ogO$~,5 زUS9 lq3+5mgw@np1sso Ӻ=|N6 /g(Wv7U;zωM=wk,0uTg_`_P`uz?2yI!b`kĸSo+Qx%!\οe|އԁKS-s6pu_(ֿ$i++T8=eY; צP+phxWQv*|p1. ά. XRkIQYP,drZ | B%wP|S5`~́@i޾ E;Չaw{o'Q?%iL{u D?N1BD!owPHReFZ* k_-~{E9b-~P`fE{AܶBJAFO wx6Rox5 K5=WwehS8 (JClJ~ p+Fi;ŗo+:bD#g(C"wA^ r.F8L;dzdIHUX݆ϞXg )IFqem%I4dj&ppT{'{HOx( Rk6^C٫O.)3:s(۳(Z?~ٻ89zmT"PLtw䥈5&b<8GZ-Y&K?e8,`I6e(֍xb83 `rzXj)F=l($Ij 2*(F?h(/9ik:I`m#p3MgLaKjc/U#n5S# m(^)=y=đx8ŬI[U]~SцA4p$-F i(R,7Cx;X=cI>{Km\ o(Tv2vx2qiiDJN,Ҏ!1f 5quBj1!8 rDFd(!WQl,gSkL1Bxg''՞^ǘ;pQ P(c_ IRujg(Wz bs#P­rz> k c&nB=q+ؔXn#r5)co*Ũ+G?7< |PQӣ'G`uOd>%Mctz# Ԫڞ&7CaQ~N'-P.W`Oedp03C!IZcIAMPUۀ5J<\u~+{9(FbbyAeBhOSܳ1 bÈT#ŠyDžs,`5}DC-`̞%r&ڙa87QWWp6e7 Rϫ/oY ꇅ Nܶըtc!LA T7V4Jsū I-0Pxz7QNF_iZgúWkG83 0eWr9 X]㾮݁#Jˢ C}0=3ݱtBi]_ &{{[/o[~ \q鯜00٩|cD3=4B_b RYb$óBRsf&lLX#M*C_L܄:gx)WΘsGSbuL rF$9';\4Ɍq'n[%p.Q`u hNb`eCQyQ|l_C>Lb꟟3hSb #xNxSs^ 88|Mz)}:](vbۢamŖ࿥ 0)Q7@0=?^k(*J}3ibkFn HjB׻NO z x}7p 0tfDX.lwgȔhԾŲ }6g E |LkLZteu+=q\Iv0쮑)QٵpH8/2?Σo>Jvppho~f>%bMM}\//":PTc(v9v!gոQ )UfVG+! 35{=x\2+ki,y$~A1iC6#)vC5^>+gǵ@1Hy٪7u;p psϰu/S <aʸGu'tD1ԝI<pg|6j'p:tպhX{o(7v],*}6a_ wXRk,O]Lܳ~Vo45rp"N5k;m{rZbΦ${#)`(Ŵg,;j%6j.pyYT?}-kBDc3qA`NWQū20/^AZW%NQ MI.X#P#,^Ebc&?XR tAV|Y.1!؅⨉ccww>ivl(JT~ u`ٵDm q)+Ri x/x8cyFO!/*!/&,7<.N,YDŽ&ܑQF1Bz)FPʛ?5d 6`kQձ λc؎%582Y&nD_$Je4>a?! ͨ|ȎWZSsv8 j(I&yj Jb5m?HWp=g}G3#|I,5v珿] H~R3@B[☉9Ox~oMy=J;xUVoj bUsl_35t-(ՃɼRB7U!qc+x4H_Qo֮$[GO<4`&č\GOc[.[*Af%mG/ ňM/r W/Nw~B1U3J?P&Y )`ѓZ1p]^l“W#)lWZilUQu`-m|xĐ,_ƪ|9i:_{*(3Gѧ}UoD+>m_?VPۅ15&}2|/pIOʵ> GZ9cmíتmnz)yߐbD >e}:) r|@R5qVSA10C%E_'^8cR7O;6[eKePGϦX7jb}OTGO^jn*媓7nGMC t,k31Rb (vyܴʭ!iTh8~ZYZp(qsRL ?b}cŨʊGO^!rPJO15MJ[c&~Z`"ѓޔH1C&^|Ш|rʼ,AwĴ?b5)tLU)F| &g٣O]oqSUjy(x<Ϳ3 .FSkoYg2 \_#wj{u'rQ>o;%n|F*O_L"e9umDds?.fuuQbIWz |4\0 sb;OvxOSs; G%T4gFRurj(֍ڑb uԖKDu1MK{1^ q; C=6\8FR艇!%\YÔU| 88m)֓NcLve C6z;o&X x59:q61Z(T7>C?gcļxѐ Z oo-08jہ x,`' ҔOcRlf~`jj".Nv+sM_]Zk g( UOPyεx%pUh2(@il0ݽQXxppx-NS( WO+轾 nFߢ3M<;z)FBZjciu/QoF 7R¥ ZFLF~#ȣߨ^<쩡ݛкvџ))ME>ώx4m#!-m!L;vv#~Y[đKmx9.[,UFS CVkZ +ߟrY٧IZd/ioi$%͝ب_ֶX3ܫhNU ZZgk=]=bbJS[wjU()*I =ώ:}-蹞lUj:1}MWm=̛ _ ¾,8{__m{_PVK^n3esw5ӫh#$-q=A̟> ,^I}P^J$qY~Q[ Xq9{#&T.^GVj__RKpn,b=`żY@^՝;z{paVKkQXj/)y TIc&F;FBG7wg ZZDG!x r_tƢ!}i/V=M/#nB8 XxЫ ^@CR<{䤭YCN)eKOSƟa $&g[i3.C6xrOc8TI;o hH6P&L{@q6[ Gzp^71j(l`J}]e6X☉#͕ ׈$AB1Vjh㭦IRsqFBjwQ_7Xk>y"N=MB0 ,C #o6MRc0|$)ف"1!ixY<B9mx `,tA>)5ػQ?jQ?cn>YZe Tisvh# GMމȇp:ԴVuږ8ɼH]C.5C!UV;F`mbBk LTMvPʍϤj?ԯ/Qr1NB`9s"s TYsz &9S%U԰> {<ؿSMxB|H\3@!U| k']$U+> |HHMLޢ?V9iD!-@x TIî%6Z*9X@HMW#?nN ,oe6?tQwڱ.]-y':mW0#!J82qFjH -`ѓ&M0u Uγmxϵ^-_\])@0Rt.8/?ٰCY]x}=sD3ojަЫNuS%U}ԤwHH>ڗjܷ_3gN q7[q2la*ArǓԖ+p8/RGM ]jacd(JhWko6ڎbj]i5Bj3+3!\j1UZLsLTv8HHmup<>gKMJj0@H%,W΃7R) ">c, xixј^ aܖ>H[i.UIHc U1=yW\=S*GR~)AF=`&2h`DzT󑓶J+?W+}C%P:|0H܆}-<;OC[~o.$~i}~HQ TvXΈr=b}$vizL4:ȰT|4~*!oXQR6Lk+#t/g lԁߖ[Jڶ_N$k*". xsxX7jRVbAAʯKҎU3)zSNN _'s?f)6X!%ssAkʱ>qƷb hg %n ~p1REGMHH=BJiy[<5 ǁJҖgKR*倳e~HUy)Ag,K)`Vw6bRR:qL#\rclK/$sh*$ 6덤 KԖc 3Z9=Ɣ=o>X Ώ"1 )a`SJJ6k(<c e{%kϊP+SL'TcMJWRm ŏ"w)qc ef꒵i?b7b('"2r%~HUS1\<(`1Wx9=8HY9m:X18bgD1u ~|H;K-Uep,, C1 RV.MR5άh,tWO8WC$ XRVsQS]3GJ|12 [vM :k#~tH30Rf-HYݺ-`I9%lIDTm\ S{]9gOڒMNCV\G*2JRŨ;Rҏ^ڽ̱mq1Eu?To3I)y^#jJw^Ńj^vvlB_⋌P4x>0$c>K†Aļ9s_VjTt0l#m>E-,,x,-W)سo&96RE XR.6bXw+)GAEvL)͞K4$p=Ũi_ѱOjb HY/+@θH9޼]Nԥ%n{ &zjT? Ty) s^ULlb,PiTf^<À] 62R^V7)S!nllS6~͝V}-=%* ʻ>G DnK<y&>LPy7'r=Hj 9V`[c"*^8HpcO8bnU`4JȪAƋ#1_\ XϘHPRgik(~G~0DAA_2p|J묭a2\NCr]M_0 ^T%e#vD^%xy-n}-E\3aS%yN!r_{ )sAw ڼp1pEAk~v<:`'ӭ^5 ArXOI驻T (dk)_\ PuA*BY]yB"l\ey hH*tbK)3 IKZ򹞋XjN n *n>k]X_d!ryBH ]*R 0(#'7 %es9??ښFC,ՁQPjARJ\Ρw K#jahgw;2$l*) %Xq5!U᢯6Re] |0[__64ch&_}iL8KEgҎ7 M/\`|.p,~`a=BR?xܐrQ8K XR2M8f ?`sgWS%" Ԉ 7R%$ N}?QL1|-эټwIZ%pvL3Hk>,ImgW7{E xPHx73RA @RS CC !\ȟ5IXR^ZxHл$Q[ŝ40 (>+ _C >BRt<,TrT {O/H+˟Pl6 I B)/VC<6a2~(XwV4gnXR ϱ5ǀHٻ?tw똤Eyxp{#WK qG%5],(0ӈH HZ])ג=K1j&G(FbM@)%I` XRg ʔ KZG(vP,<`[ Kn^ SJRsAʠ5xՅF`0&RbV tx:EaUE/{fi2;.IAwW8/tTxAGOoN?G}l L(n`Zv?pB8K_gI+ܗ #i?ޙ.) p$utc ~DžfՈEo3l/)I-U?aԅ^jxArA ΧX}DmZ@QLےbTXGd.^|xKHR{|ΕW_h] IJ`[G9{).y) 0X YA1]qp?p_k+J*Y@HI>^?gt.06Rn ,` ?);p pSF9ZXLBJPWjgQ|&)7! HjQt<| ؅W5 x W HIzYoVMGP Hjn`+\(dNW)F+IrS[|/a`K|ͻ0Hj{R,Q=\ (F}\WR)AgSG`IsnAR=|8$}G(vC$)s FBJ?]_u XRvύ6z ŨG[36-T9HzpW̞ú Xg큽=7CufzI$)ki^qk-) 0H*N` QZkk]/tnnsI^Gu't=7$ Z;{8^jB% IItRQS7[ϭ3 $_OQJ`7!]W"W,)Iy W AJA;KWG`IY{8k$I$^%9.^(`N|LJ%@$I}ֽp=FB*xN=gI?Q{٥4B)mw $Igc~dZ@G9K X?7)aK%݅K$IZ-`IpC U6$I\0>!9k} Xa IIS0H$I H ?1R.Чj:4~Rw@p$IrA*u}WjWFPJ$I➓/6#! LӾ+ X36x8J |+L;v$Io4301R20M I$-E}@,pS^ޟR[/s¹'0H$IKyfŸfVOπFT*a$I>He~VY/3R/)>d$I>28`Cjw,n@FU*9ttf$I~<;=/4RD~@ X-ѕzἱI$: ԍR a@b X{+Qxuq$IЛzo /~3\8ڒ4BN7$IҀj V]n18H$IYFBj3̵̚ja pp $Is/3R Ӻ-Yj+L;.0ŔI$Av? #!5"aʄj}UKmɽH$IjCYs?h$IDl843.v}m7UiI=&=0Lg0$I4: embe` eQbm0u? $IT!Sƍ'-sv)s#C0:XB2a w I$zbww{."pPzO =Ɔ\[ o($Iaw]`E).Kvi:L*#gР7[$IyGPI=@R 4yR~̮´cg I$I/<tPͽ hDgo 94Z^k盇΄8I56^W$I^0̜N?4*H`237}g+hxoq)SJ@p|` $I%>-hO0eO>\ԣNߌZD6R=K ~n($I$y3D>o4b#px2$yڪtzW~a $I~?x'BwwpH$IZݑnC㧄Pc_9sO gwJ=l1:mKB>Ab<4Lp$Ib o1ZQ@85b̍ S'F,Fe,^I$IjEdù{l4 8Ys_s Z8.x m"+{~?q,Z D!I$ϻ'|XhB)=…']M>5 rgotԎ 獽PH$IjIPhh)n#cÔqA'ug5qwU&rF|1E%I$%]!'3AFD/;Ck_`9 v!ٴtPV;x`'*bQa w I$Ix5 FC3D_~A_#O݆DvV?<qw+I$I{=Z8".#RIYyjǪ=fDl9%M,a8$I$Ywi[7ݍFe$s1ՋBVA?`]#!oz4zjLJo8$I$%@3jAa4(o ;p,,dya=F9ً[LSPH$IJYЉ+3> 5"39aZ<ñh!{TpBGkj}Sp $IlvF.F$I z< '\K*qq.f<2Y!S"-\I$IYwčjF$ w9 \ߪB.1v!Ʊ?+r:^!I$BϹB H"B;L'G[ 4U#5>੐)|#o0aڱ$I>}k&1`U#V?YsV x>{t1[I~D&(I$I/{H0fw"q"y%4 IXyE~M3 8XψL}qE$I[> nD?~sf ]o΁ cT6"?'_Ἣ $I>~.f|'!N?⟩0G KkXZE]ޡ;/&?k OۘH$IRۀwXӨ<7@PnS04aӶp.:@\IWQJ6sS%I$e5ڑv`3:x';wq_vpgHyXZ 3gЂ7{{EuԹn±}$I$8t;b|591nءQ"P6O5i }iR̈́%Q̄p!I䮢]O{H$IRϻ9s֧ a=`- aB\X0"+5"C1Hb?߮3x3&gşggl_hZ^,`5?ߎvĸ%̀M!OZC2#0x LJ0 Gw$I$I}<{Eb+y;iI,`ܚF:5ܛA8-O-|8K7s|#Z8a&><a&/VtbtLʌI$I$I$I$I$I$IRjDD%tEXtdate:create2022-05-31T04:40:26+00:00!Î%tEXtdate:modify2022-05-31T04:40:26+00:00|{2IENDB`Mini Shell

HOME


Mini Shell 1.0
DIR:/home/dna1981/mail/.spam/new/
Upload File :
Current File : /home/dna1981/mail/.spam/new/1640681225.M673083P19599.dna.dna-1981.com,S=11247,W=11492
Return-Path: <tuftwww1245@gmail.com>
Delivered-To: dna1981+spam@dna.dna-1981.com
Received: from dna.dna-1981.com
	by dna.dna-1981.com with LMTP
	id TRJpJwnPymGPTAAAff7CYA
	(envelope-from <tuftwww1245@gmail.com>)
	for <dna1981+spam@dna.dna-1981.com>; Tue, 28 Dec 2021 02:47:05 -0600
Return-path: <tuftwww1245@gmail.com>
Envelope-to: cwilson@smithfamilycarpets.com
Delivery-date: Tue, 28 Dec 2021 02:47:05 -0600
Received: from mail-pl1-f194.google.com ([209.85.214.194]:45881)
	by dna.dna-1981.com with esmtps  (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256
	(Exim 4.94.2)
	(envelope-from <tuftwww1245@gmail.com>)
	id 1n288J-00055L-Ih
	for cwilson@smithfamilycarpets.com; Tue, 28 Dec 2021 02:47:05 -0600
Received: by mail-pl1-f194.google.com with SMTP id w24so13088355ply.12
        for <cwilson@smithfamilycarpets.com>; Tue, 28 Dec 2021 00:46:40 -0800 (PST)
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
        d=gmail.com; s=20210112;
        h=message-id:mime-version:content-transfer-encoding
         :content-description:subject:to:from:date;
        bh=LSJc2rWvgzgo/4z0djrIcPcfweE6ao10uoR9r/S/mFE=;
        b=HvaPaPxItvnGxxQsTTn1f+VYzIUsLpA2xmskHVTcmhVy4B9pJl6d55isP2Yn9MwC+J
         wYKVyEDDNPuV95bnWRZttXr6BT3SmrVN2UGvm77yWwcm+VCdDFu4ajuCGlCcxleYr5Nc
         +Yt0x4W0UqrfojIUPcEESkSEUmilXU5zFDUQ2VPULHfFsYf+hp6EwcKc2+9+DCLpNJFb
         k6PXLK65LUj44H/neW+PzclYrgqrp8S7dYS7DREhCX/1uU3ApMRFPWJta7ZhQ/C9sccL
         iU1BCZt571z2hcr5NC0OkUbNvC2cj22Fy8YEBAnP/9wTh82ZkWkAx/am+K9I4wAuei5G
         bRhA==
X-Google-DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
        d=1e100.net; s=20210112;
        h=x-gm-message-state:message-id:mime-version
         :content-transfer-encoding:content-description:subject:to:from:date;
        bh=LSJc2rWvgzgo/4z0djrIcPcfweE6ao10uoR9r/S/mFE=;
        b=j5fvNs8kdhROiKycZqPwXWVBLCpOo5qFxTECjBfzlQaKnXBJd4uiuXqHmWGvK3E43F
         3jYbkXLGPqbQiFfH+7nD5t+ZujY9a8//yj1mtk6MZf6lLcAvimVXeG63kiphCOzkGFW0
         N14f6g+8xYpfaFAGgJp+woFv37+nYJ11F1614AIgiC2UqKWqaEp0aD3/lBFEY2gKNqNq
         eleNq4kfOI3sCDmy7R94aM3yNBCBz3drCjCPA0VfQqlyCoWCxhJIv7pJGrF7YiUXMbrA
         4HZXz9EFYqtnIspGG3Dr73rY9X75Ne6vRpgwJVAoj13kAYnVGFYtUbF7igQ715o5lOuk
         uZmQ==
X-Gm-Message-State: AOAM533pCBW3YGSQBH4nquKCKD77lVHhgU1t+MuuuxgLjB72S/hTO2ov
	jRCfnls4Po3zKr2N1cgnacSwXbu/JyU=
X-Google-Smtp-Source: ABdhPJx1JAhkqB7GQdTXBHbZW9LdXATVSOMgwdC5bYU+9WjYnk5T7w5l/vScx3v9M1vONZYiuiInFQ==
X-Received: by 2002:a17:902:e5c8:b0:149:14b:f2da with SMTP id u8-20020a170902e5c800b00149014bf2damr20682898plf.110.1640681178827;
        Tue, 28 Dec 2021 00:46:18 -0800 (PST)
Received: from [192.168.0.107] ([125.63.112.173])
        by smtp.gmail.com with ESMTPSA id k8sm13740611pjs.53.2021.12.28.00.46.17
        for <cwilson@smithfamilycarpets.com>
        (version=TLS1 cipher=AES128-SHA bits=128/128);
        Tue, 28 Dec 2021 00:46:18 -0800 (PST)
Message-ID: <61caceda.1c69fb81.4818e.74ce@mx.google.com>
Content-Type: text/plain; charset="utf-8"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
To: cwilson@smithfamilycarpets.com
From: "Charlotte" <tuftwww1245@gmail.com>
Date: Tue, 28 Dec 2021 14:16:17 +0530
X-Spam-Status: Yes, score=8.8
X-Spam-Score: 88
X-Spam-Bar: ++++++++
X-Spam-Report: Spam detection software, running on the system "dna.dna-1981.com",
 has identified this incoming email as possible spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\@localhost for details.
 Content preview:  Vaccines continue to reduce a person’s risk of contracting
    the virus that cause COVID-19, including this variant. Vaccines are highly
    effective against severe illness, but the Delta variant causes m [...] 
 Content analysis details:   (8.8 points, 4.0 required)
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
  5.0 BAYES_99               BODY: Bayes spam probability is 99 to 100%
                             [score: 1.0000]
  1.0 BAYES_999              BODY: Bayes spam probability is 99.9 to 100%
                             [score: 1.0000]
  1.3 RCVD_IN_VALIDITY_RPBL  RBL: Relay in Validity RPBL,
                             https://senderscore.org/blocklistlookup/
                            [209.85.214.194 listed in bl.score.senderscore.com]
  1.0 HK_RANDOM_FROM         From username looks random
  0.5 HK_RANDOM_ENVFROM      Envelope sender username looks random
  0.2 FREEMAIL_ENVFROM_END_DIGIT Envelope-from freemail username ends
                             in digit
                             [tuftwww1245[at]gmail.com]
 -0.0 SPF_PASS               SPF: sender matches SPF record
  0.0 FREEMAIL_FROM          Sender email is commonly abused enduser mail
                             provider
                             [tuftwww1245[at]gmail.com]
 -0.1 DKIM_VALID_AU          Message has a valid DKIM or DK signature from
                             author's domain
  0.1 DKIM_SIGNED            Message has a DKIM or DK signature, not necessarily
                             valid
 -0.1 DKIM_VALID_EF          Message has a valid DKIM or DK signature from
                             envelope-from domain
 -0.1 DKIM_VALID             Message has at least one valid DKIM or DK signature
X-Spam-Flag: YES
Subject:    Need to Know about Covid-19 Variants

Vaccines continue to reduce a person=E2=80=99s risk of contracting the viru=
s that cause COVID-19, including this variant. Vaccines are highly effectiv=
e against severe illness, but the Delta variant causes more infections and =
spreads faster than earlier forms of the virus that causes COVID-19.

Viruses constantly change through mutation, and new variants of a virus are=
 expected to occur. Sometimes new variants emerge and disappear. Other time=
s, new variants persist. Numerous variants of the virus that causes COVID-1=
9 are being tracked in the United States and globally during this pandemic.

Top Things You Need to Know

Variants are expected. The best way to slow the emergence of new variants i=
s to reduce the spread of infection by taking measures to protect yourself =
including getting a COVID-19 vaccine when available.

Vaccines keep you from getting sick, being hospitalized, or dying from COVI=
D-19.
All COVID-19 tests can detect all variants, but they will not tell you whic=
h variant you have.
viruses light icon

Vaccines =


FDA-approved or authorized a COVID-19 vaccines protect against Delta and ot=
her known variants.
These vaccines are effective at keeping people from getting COVID-19, getti=
ng very sick, and dying.
We don=E2=80=99t yet know how effective the vaccines will be against new va=
riants that may arise.
lungs virus light icon


Symptoms =

Most variants cause similar COVID-19 symptoms.
Some variants may cause more people to get sicker and die, for example, Alp=
ha and Delta variants.
head side mask light icon

Masks
Wearing a mask is one way to reduce the spread of Delta and other variants.
People who are not fully vaccinated should wear a mask indoors in public at=
 all levels of community transmission.
CDC recommends that people who are fully vaccinated should wear a mask indo=
ors in areas of substantial or high transmission.

Wearing a mask is most important if you have a weakened immune system or if=
, because of your age or an underlying medical condition, you are at increa=
sed risk for severe disease, or if someone in your household has a weakened=
 immune system, is at increased risk for severe disease, or is unvaccinated=
. If this applies to you or your household, you might choose to wear a mask=
 regardless of the level of transmission in your area.
If you have a condition or are taking medications that weaken your immune s=
ystem, you may not be fully protected even if you are fully vaccinated. You=
 should continue to take all precautions recommended for unvaccinated peopl=
e until advised otherwise by your healthcare provider.
People who are NOT vaccinated, should continue to take steps to protect the=
mselves.
vials light icon

Testing =

All tests work for all variants, but they will not tell you which variant y=
ou have.
As new variants emerge, scientists will continue to evaluate how well tests=
 work.
Types of Variants
Scientists monitor all variants but may classify certain ones as variants o=
f interest, concern, or high consequence based on how easily they spread, h=
ow severe their symptoms are, and how they are treated.

Some variants seem to spread more easily and quickly than other variants, w=
hich may lead to more cases of COVID-19. An increase in the number of cases=
 will put more strain on healthcare resources, lead to more hospitalization=
s, and potentially more deaths.

Variants of Concern in the US
illustration of virus in blue
Alpha - B.1.1.7
First identified:?United Kingdom

Spread: Much faster than other variants

Severe illness and death: May potentially cause more people to get sicker a=
nd to die

Vaccine: Currently FDA approved or authorized vaccines do work against this=
 variant. Some breakthrough infections in fully vaccinated people are expec=
ted but remain rare. All vaccines are particularly effective against severe=
 illness, hospitalization, and death.

Treatments: Treatments are effective against this variant.

illustration of virus in pink
Beta - B.1.351
First identified:?South Africa

Spread: May spread faster than other variants

Severe illness and death: Current data do not indicate more severe illness =
or death than other variants

Vaccine: Currently FDA approved or authorized vaccines do work against this=
 variant. Some breakthrough infections are expected but remain rare. All va=
ccines are particularly effective against severe illness, hospitalization a=
nd death.

Treatments: Certain monoclonal antibody treatments are less effective again=
st this variant.

illustration of virus in orange
Gamma - P.1
First identified: Japan/Brazil

Spread: Faster than other variants

Severe illness and death: Current data do not indicate more severe illness =
or death than other variants

Vaccine: Currently FDA approved or authorized vaccines do work against this=
 variant. Some breakthrough infections are expected but remain rare. All va=
ccines are particularly effective against severe illness, hospitalization a=
nd death.

Treatments: Certain monoclonal antibody treatments are less effective again=
st this variant.

illustration of virus in green
Delta - B.1.617.2
First identified: India

Spread: Much faster than other variants

Severe illness and death: May cause more severe cases than the other varian=
ts

Vaccine: Infections happen in only a small proportion of people who are ful=
ly vaccinated, even with the Delta variant.?Some breakthrough infections ar=
e expected but remain rare. However, preliminary evidence suggests that ful=
ly vaccinated people who do become infected with the Delta variant can spre=
ad the virus to others. All vaccines are particularly effective against sev=
ere illness, hospitalization and death.

Treatments: Certain monoclonal antibody treatments are less effective again=
st this variant.